Topical therapy for oropharyngeal symptoms of myasthenia gravis
暂无分享,去创建一个
[1] O. Paulson,et al. Steady state kinetics of pyridostigmine in myasthenia gravis , 1984, Neurology.
[2] S. Clarke,et al. Therapeutic aerosols 1--physical and practical considerations. , 1983, Thorax.
[3] J. Riggs. Pharmacologic Enhancement of Neuromuscular Transmission in Myasthenia Gravis , 1982, Clinical neuropharmacology.
[4] A. Dehghan,et al. The relationship of plasma levels of pyridostigmine to clinical effect in patients with myasthenia gravis , 1981, Journal of neurology, neurosurgery, and psychiatry.
[5] S. Cohan,et al. Malabsorption of pyridostigmine in patients with myasthenia gravis , 1977, Neurology.